Search
Patexia Research
Case number IPR2016-01027

Amneal Pharmaceuticals, LLC v. PURDUE PHARMA L.P. > Documents

Date Field Doc. No.PartyDescription
Dec 11, 2018 50 Updated Mandatory Notices (-01027) - remove K. Canfield as counsel Download
Dec 4, 2017 49 Patent Owners' Notice of Appeal IPR2016-01027 Download
Nov 8, 2017 48 Final Written Decision - Determining That Claim 1 Has Been Shown To Be Unpatentable Download
Nov 2, 2017 3001 Parties (August 10th 2017) Email Construction Agreement Regarding the Term Core Matrix Download
Oct 6, 2017 47 Hearing Transcript Download
Sep 27, 2017 46 Petitioner's Updated Mandatory Notices Pursuant To 37 C.F.R. 42.8(a)(3) Download
Jul 31, 2017 45 Petitioner's Updated Mandatory Notices Download
Jul 26, 2017 43 Patent Owners' Demonstratives IPR2016-01027 Download
Jul 26, 2017 44 Petitioner's Demonstratives for Oral Argument Download
Jul 20, 2017 41 Patent Owners' Reply in Support of Motion to Exclude Download
Jul 20, 2017 42 Reply To Patent Owners' Opposition To Petitioner's Motion To Exclude Evidence Download
Jul 14, 2017 40 Patent Owners' Surreply IPR2016-01027 Download
Jul 13, 2017 35 Patent Owners' Opposition to Motion to Exclude (2016-01027) Download
Jul 13, 2017 39 Opposition to Patent Owners' Motion to Exclude Download
Jul 13, 2017 38 Response to Patent Owners¿¿¿ Observations on Cross Examination of Dr. Robert J. Timko Download
Jul 13, 2017 2150 2150 Application No. 14728601 Jan 26 2017 Non Final Rejection Download
Jul 13, 2017 2153 2153 Application No. 14733659 Jan 18 2017 Non Final Rejection Download
Jul 13, 2017 2154 2154 Application No. 14733659 Final Rejection Download
Jul 13, 2017 37 Response to Patent Owners¿¿¿ Observations on Cross Examination of Dr. Thomas Vander Veen Download
Jul 13, 2017 36 Patent Owners' Updated Exhibit List (2016-01027) Download
Jul 13, 2017 2152 2152 Application No. 14733659 Dec 15 2016 RCE Download
Jul 13, 2017 2151 2151 Application No. 14728601 Final Rejection Download
Jul 13, 2017 2149 2149 Application No. 14728601 Dec 8 2016 RCE Download
Jul 12, 2017 34 Patent Owners' Updated Mandatory Notice (-01027) Download
Jul 7, 2017 33 Oral Hearing Order Download
Jul 7, 2017 32 Order - re Conference Call (7/3/2017) Download
Jun 30, 2017 2144 U.S. Patent Application No. 08/864,306 Download
Jun 30, 2017 2145 Combined Declaration and Power of Attorney for U.S. Patent Application No. 11/939,585 Download
Jun 30, 2017 2146 U.S. Patent Application Publication No. 2008/0287418 Download
Jun 30, 2017 2147 Deposition of Dr. Timko (June 22, 2017) Download
Jun 30, 2017 2148 Deposition of Dr. Vander Veen (June 27, 2017) Download
Jun 30, 2017 27 Patent Owners' Motion to Exclude Evidence Download
Jun 30, 2017 28 Patent Owners' Updated Exhibit List Download
Jun 30, 2017 29 Patent Owners' Observations on Timko Cross Examination Download
Jun 30, 2017 30 Patent Owner - Observations on Vander Veen Cross-Examination Download
Jun 30, 2017 31 Download
Jun 29, 2017 26 PETITIONER¿¿¿S REQUEST FOR ORAL ARGUMENT Download
Jun 29, 2017 25 Patent Owners' Request for Oral Hearing (IPR2016-01027) Download
May 30, 2017 24 Patent Owners' Notice of Deposition of Dr. Vander Veen Download
May 30, 2017 23 Patent Owners' Notice of Deposition of Dr. Timko Download
May 25, 2017 1127 Purdue Pharma L.P. et al. v. Teva Pharmaceuticals LLC, No. 11-cv-2037 and 12-cv-5083 (S.D.N.Y. Jan. 14, 2014) Finding of Facts and Conclusion of Law Download
May 25, 2017 22 Petitioner's Exhibit List Download
May 22, 2017 21 Patent Owners' Objections to Evidence After Institution Download
May 15, 2017 1109 U.S. Patent No. 7,776,314 Download
May 15, 2017 1123 FDA Perspective on Assessment of Drugs Download
May 15, 2017 1100 Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations Download
May 15, 2017 1103 Guha et al. Download
May 15, 2017 1101 Chisum on Patents A Treatise on the Law of Patentability, Validity and Infringement Sect. 5.05, at 633-734 Download
May 15, 2017 1115 U.S. Patent No. 9,492,389 Download
May 15, 2017 1076 Remington, Ch. 94 - Sustained-Release Drug Delivery System Download
May 15, 2017 1112 U.S. Patent No. 8,804,741 Download
May 15, 2017 1108 Approved Drug Products with Therapeutic Equivalence Evaluations Download
May 15, 2017 1104 Crouch, Objective Indicia on Non-Obviousness Must be Tied to Inventive Step Download
May 15, 2017 1105 Kolassa, Elements of Pharmaceutical Pricing Download
May 15, 2017 1075 Guidance for Industry: SUPAC-MR Download
May 15, 2017 1120 Finding of Facts and Conclusion of Law, Purdue v. Teva Download
May 15, 2017 1107 MPEP Sect. 716.03 Download
May 15, 2017 1073 Meunier - Multicomponent Biopolymer Gels Download
May 15, 2017 1118 U.S. Patent No. 9,492,393 Download
May 15, 2017 1116 U.S. Patent No. 9,492,391 Download
May 15, 2017 1125 Senator to investigate opioid makers¿¿¿ role in drug crisis Download
May 15, 2017 1121 Center for Drug Evaluation and Research, Application Number 22 272 Download
May 15, 2017 1110 U.S. Patent No. 8,114,383 Download
May 15, 2017 1111 U.S. Patent No. 8,309,060 Download
May 15, 2017 1074 Bailey et al., POLYOX, High Molecular Weight Polymers of Ethylene Oxide Download
May 15, 2017 1117 U.S. Patent No. 9,492,392 Download
May 15, 2017 1114 U.S. Patent No. 8,894,988 Download
May 15, 2017 1106 Gunul et al., Promotion of Prescription Drugs and Its Impact on Physicians¿¿¿ Choice Behavior Download
May 15, 2017 1113 U.S. Patent No. 8,894,987 Download
May 15, 2017 1072 Zasypkin et al. Download
May 15, 2017 20 Petitioner's Reply to Patent Owner's Response Download
May 15, 2017 1122 Guidance for Industry: Abuse-Deterrent Opioids Evaluation and Labeling Download
May 15, 2017 1102 Commercial Success: Economic Principles Applied to Patent Litigation, Ch. 9 Download
May 15, 2017 1124 Advancements in Opioid Abuse Deterrence Download
May 15, 2017 1119 Purdue Brief Download
May 15, 2017 1126 Time for opioid makers to come clean and help addicts go clean Download
May 15, 2017 1040 Declaration of Robert J. Timko, Ph.D. in Support of Petitioner's Reply Download
May 15, 2017 1059 Follonier et al. Download
May 15, 2017 1065 U.S. Patent No. 5,223,264 Download
May 15, 2017 1070 Oxycodone, Merck Index 1194 (12 ed. 1996) Download
May 15, 2017 1044 U.S. Patent No. 9,034,376 Download
May 15, 2017 1064 U.S. Patent No. 3,822,343 Download
May 15, 2017 1056 Chernug ju Kim, Effects of Drug Solubility, Drug Loading Download
May 15, 2017 1040 Declaration of Robert J. Timko, Ph.D. in Support of Petitioner's Reply Download
May 15, 2017 1062 U.S. Patent No. 5,266,331 Download
May 15, 2017 1053 Dimitrov Download
May 15, 2017 1052 Brunella Cappello et al. Download
May 15, 2017 1069 Remington, Ch. 93 - Coating of Pharmaceutical Dosage Forms Download
May 15, 2017 1060 Carstensen Download
May 15, 2017 1066 Remington, Ch. 92 - Lubricants Download
May 15, 2017 1041 Curriculum Vitae of Robert Timko, Ph.D. Download
May 15, 2017 1067 U.S. Patent No. 5,948,437 Download
May 15, 2017 1061 PDR Reference - REVIA, DILAUDID, TYLOX, TALWIN Download
May 15, 2017 1068 Maniruzzaman et al. Download
May 15, 2017 1051 Apicella et al. Download
May 15, 2017 1042 Declaration of Dr. Thomas Vander Veen Download
May 15, 2017 1057 Moroni and Ghebre Sellassie Download
May 15, 2017 1055 Cherng ju Kim, Drug Release from Compressed Hydrophilic POLYOX-WSR Tablets Download
May 15, 2017 1043 Curriculum Vitae of Thomas Vander Veen, Ph.D. Download
May 15, 2017 1054 Efentakis Download
May 15, 2017 1063 U.S. Patent No. 5,178,878 Download
May 15, 2017 1058 Yang et al. Download
May 15, 2017 1040 Declaration of Robert J. Timko, Ph.D. in Support of Petitioner's Reply Download
May 5, 2017 19 Notice of Joint Stipulation to Modify Due Dates 2 and 4 Download
Feb 15, 2017 18 PETITIONER¿¿¿S OBJECTIONS UNDER 37 C.F.R. ¿¿ 42.64 TO EVIDENCE SUBMITTED BY PATENT OWNERS POST-INSTITUTION Download
Feb 8, 2017 2122 2122 Kim - 84 J Pharm Sci 303 Download
Feb 8, 2017 2139 2139 Thompson - 58 Am Jnl of Health-System Pharmacy 956 Download
Feb 8, 2017 2123 2123 Madorsky - 36 J Polym Sci 183 Download
Feb 8, 2017 2143 2143 Baker - Controlled Release of Biologically Active Agents (1987) Download
Feb 8, 2017 2100 2100 U.S. Patent No. 5,508,042 Download
Feb 8, 2017 2129 2129 U.S. Patent No. 6,177,567 Download
Feb 8, 2017 2132 2132 Handbook of Pharmaceutical (Magnesium Stearate) Download
Feb 8, 2017 2098 2098 Wright Declaration in Support of Patent Owner Response Download
Feb 8, 2017 2131 2131 Craig - 179 Int'l. J. Pharm. 179 Download
Feb 8, 2017 2113 2113 Zhang - 4 Pharm Dev Technol 241 Download
Feb 8, 2017 2102 2102 U.S. Patent No. 5,266,331 Download
Feb 8, 2017 2136 2136 Downie - 7 Hospital Pharmacist 242 Download
Feb 8, 2017 2099 2099 Deposition of Dr. Palmieri (January 13, 2017) Download
Feb 8, 2017 2112 2112 FDA Guidance for Industry 1997 Download
Feb 8, 2017 2137 2137 Brookoff - 8 Jnl of General Internal Medicine 688 Download
Feb 8, 2017 2135 2135 Bossert - 6 Drug Dev. + Indus. Pharm. 573 Download
Feb 8, 2017 2110 2110 Coplan - 100 Clin Pharm Therap 275 Download
Feb 8, 2017 2103 2103 U.S. Patent No. 5,656,295 Download
Feb 8, 2017 2097 2097 Oshlack Declaration in Support of Patent Owner Response Download
Feb 8, 2017 2128 2128 Salomies - 83 J AOAC Int'l 1497 Download
Feb 8, 2017 17 Patent Owners' Response to Petition for Inter Partes Review Download
Feb 8, 2017 2109 2109 Severtson - 168 Drug and Alcohol Dep 219 Download
Feb 8, 2017 2125 2125 Alderman - 5 In¿¿¿l J. Pharm. Tech. Prod. Mfr. 1 Download
Feb 8, 2017 2133 2133 Ragnarsson - 3 Int'l. J. Pharm. 127 Download
Feb 8, 2017 2111 2111 Frederichs - Opioids overview Buschmann, Friderichs 2002 Download
Feb 8, 2017 2134 2134 Murthy - 66 J Pharm Sci 1215 Download
Feb 8, 2017 2114 2114 Zhang - 26 Drug Dev Ind Pharm 931 Download
Feb 8, 2017 2096 2096 Byrn Declaration ISO Patent Owner Response to Petition Download
Feb 8, 2017 2115 2115 McGinity - 4 Am Pharm Rev 25 Download
Feb 8, 2017 2130 2130 Brogle - 19 J. Pharm and Biomed. Analysis 669 Download
Feb 8, 2017 16 Patent Owners' Motion to Seal Download
Feb 8, 2017 2127 2127 Poyhia - 8 Jnl of Pain and Symptom Mgmt 63 Download
Feb 8, 2017 2118 2118 Crowley - 23 Biomaterials 4241 Download
Feb 8, 2017 2138 2138 Chernin - Painkillers and Pill Popping Download
Feb 8, 2017 2095 2095 HPE 3rd ed (2000) TOC and Index Download
Feb 8, 2017 2124 2124 McGary - 46 J Polym Sci 51 Download
Feb 8, 2017 2116 2116 Follonier - 20 Drug Dev Ind Pharm 1323 Download
Feb 8, 2017 2141 2141 U.S. Patent No. 6,067,749 Download
Feb 8, 2017 2142 2142 Byrn - Solid State Acid Base Reactions Download
Feb 8, 2017 2101 2101 U.S. Patent No. 5,549,912 Download
Feb 8, 2017 2140 2140 Letter to Pablo Hendler Download
Nov 15, 2016 15 Joint Motion for Entry of Stipulated Protective Order Download
Nov 9, 2016 13 Decision - Institution of Inter Partes Review Download
Nov 9, 2016 14 Scheduling Order Download
Aug 31, 2016 12 Order - Patent Owner's Motions for Pro Hac Vice Admission Download
Aug 12, 2016 2046 2046 ADFs-A Tale of Two ADFs-TJ Cicero Pain 2016 Download
Aug 12, 2016 2004 2004 '324 FH IDS 2013-06-05 Download
Aug 12, 2016 2051 2051 FDA approves abuse-deterrent labeling for reformulated OxyContin Download
Aug 12, 2016 2054 2054 Actavis press release Download
Aug 12, 2016 2033 2033 Throckmorton, FDA Voice Download
Aug 12, 2016 2055 2055 Endo to FDA, Opana reformulation citizen petition Download
Aug 12, 2016 2068 2068 2014.03.11 Xartemis XR Download
Aug 12, 2016 2047 2047 FDA Statement Original Opana ER Relisting Determination Download
Aug 12, 2016 2059 2059 2011.04.20 Opana ER Download
Aug 12, 2016 2069 2069 2012.07.09 Avinza Download
Aug 12, 2016 2078 2078 2015.04 Generic methadone HCl tablet Download
Aug 12, 2016 2034 2034 14-733,659 FH NOA 2016-08-01 Download
Aug 12, 2016 2009 2009 '324 FH Comments on 2nd NOA 2015-05-18 Download
Aug 12, 2016 2073 2073 2012.07.09 Dolophine Download
Aug 12, 2016 2012 2012 CPDD Paper 2003 Download
Aug 12, 2016 2006 2006 '324 FH Eaminer Refs 2015-05-12 Download
Aug 12, 2016 2023 2023 Joshi WO_2002_087558_A1 Download
Aug 12, 2016 2045 2045 2012 Endo press release announcing reformulation Download
Aug 12, 2016 2027 2027 QOS 10-40mg (excerpt) Download
Aug 12, 2016 2057 2057 2010.04.05 Oxycontin Download
Aug 12, 2016 2020 2020 MW 'core' 2001 Download
Aug 12, 2016 2041 2041 PUBLIC Expert Declaration of Eric M. Gaier PhD_Redacted (2) Download
Aug 12, 2016 2091 2091 PDR 1997 Download
Aug 12, 2016 2024 2024 CPDD Article - author info Download
Aug 12, 2016 2090 2090 UCM187629 2009 AdComm Minutes Download
Aug 12, 2016 2089 2089 UCM183205 2009 AdComm FDA briefing doc Download
Aug 12, 2016 2002 2002 '324 FH Misc. Action 2014-04-07 Download
Aug 12, 2016 2016 2016 OxyContin labeling 4-2013 Download
Aug 12, 2016 2035 2035 HPE-3rd Gelling agents Download
Aug 12, 2016 2048 2048 Chou 2009, Clinical Guidelines for the Use of Chronic Opioid Therapy Download
Aug 12, 2016 2021 2021 '324 FH IDS 2015-01-05 Download
Aug 12, 2016 2031 2031 Scheirs, Solid state degradation of PEO Download
Aug 12, 2016 2022 2022 '324 FH Examiner Refs 2015-05-12 Download
Aug 12, 2016 2037 2037 HPE-3rd Plasticizers Download
Aug 12, 2016 2093 2093 Wright Testimony Download
Aug 12, 2016 2088 2088 Sept. 2009 Purdue AdCom slides Download
Aug 12, 2016 2058 2058 2010.06.30 Butrans Approval Download
Aug 12, 2016 2081 2081 2004.03.24 Generic oxycodone ER Download
Aug 12, 2016 2071 2071 2008.02.20 Ultram ER Download
Aug 12, 2016 2064 2064 2007.04.20 Kadian Download
Aug 12, 2016 2070 2070 2010.05.11 MS Contin Download
Aug 12, 2016 2082 2082 Generic Hydromorpohone HCl ER Download
Aug 12, 2016 2061 2061 2009.07.31 Duragesic Download
Aug 12, 2016 2011 2011 14-728,601 FH NOA 2016-03-10 Download
Aug 12, 2016 2072 2072 2014.04 Methadose tablet Download
Aug 12, 2016 2039 2039 Maurin Testimony Download
Aug 12, 2016 2086 2086 May 2008 AdComm minutes Download
Aug 12, 2016 2083 2083 Sessler et al 2014, Reductions in reported deaths following the... Download
Aug 12, 2016 2085 2085 C8275 OXY field card Download
Aug 12, 2016 2038 2038 Merck Index Download
Aug 12, 2016 2014 2014 Cicero 2016 Download
Aug 12, 2016 2029 2029 PolyOx brochure Download
Aug 12, 2016 2040 2040 5549912 Download
Aug 12, 2016 2015 2015 UCM332288 (FDA opioid timeline) Download
Aug 12, 2016 2074 2074 2007.05 Oramorph SR Download
Aug 12, 2016 2094 2094 Proposed Protective Order (1027) Download
Aug 12, 2016 2036 2036 HPE-3rd Lubricants Download
Aug 12, 2016 2005 2005 '324 FH Examiner Refs 2013-07-09 Download
Aug 12, 2016 2018 2018 Levina, Effect of drug and excipients on release Download
Aug 12, 2016 2008 2008 OxyContin labeling 8-2015 Download
Aug 12, 2016 2063 2063 2013.10.25 Zohydro ER Download
Aug 12, 2016 2079 2079 2015.10.20 Generic Tramadol HCl ER Download
Aug 12, 2016 2030 2030 Attorneys General letter Download
Aug 12, 2016 2080 2080 2014.04.16 Generic oxymorphone HCl Download
Aug 12, 2016 2092 2092 Oshlack Testimony Download
Aug 12, 2016 9 IPR2016-01027 Preliminary Response Download
Aug 12, 2016 2076 2076 1998.07.02 Generic morphine sulfate Download
Aug 12, 2016 2065 2065 2010.03.01 Exalgo Download
Aug 12, 2016 2019 2019 Vazquez, Influence of technological variables on release of drugs... Download
Aug 12, 2016 2007 2007 Byrn Declaration Download
Aug 12, 2016 2032 2032 Abuse-Deterrent Opioids draft guidance Download
Aug 12, 2016 2075 2075 2008.12.30 Ryzolt Download
Aug 12, 2016 2017 2017 FDA Determination 2013-04-16 Download
Aug 12, 2016 2067 2067 2010.05.07 Conzip Download
Aug 12, 2016 2010 2010 '449 FH Amendment 2012-10-01 Download
Aug 12, 2016 11 Patent Owner's Exhibit List 2016-08-12 Download
Aug 12, 2016 2028 2028 QOS 60-80mg (excerpt) Download
Aug 12, 2016 2062 2062 2014.11.20 Hysingla ER Download
Aug 12, 2016 2025 2025 FDA Devel. Reg. Abuse-Deterrent Opioid 2014-10-30 Download
Aug 12, 2016 2066 2066 2009.08.13 Embeda Download
Aug 12, 2016 2077 2077 2014.05 Generic fentanyl patch Download
Aug 12, 2016 2001 2001 Interference 106,004 Request Adverse Judgment Download
Aug 12, 2016 2060 2060 2011.08.25 Nucynta ER Download
Aug 12, 2016 2084 2084 0PO571 (C8559) Download
Aug 12, 2016 2052 2052 Endo announces Opana first launch Download
Aug 12, 2016 2003 2003 Interference 106,004 Judgment Download
Aug 12, 2016 2087 2087 Weingarten Testimony Download
Aug 12, 2016 2053 2053 Butler 2013, Abuse rates and routes Download
Aug 12, 2016 2049 2049 FDA orange book Download
Aug 12, 2016 10 IPR2016-01027 Patent Owner's Motion To Seal Download
Jun 14, 2016 7 patent_own Amneal IPR - Normile Pro Hac Motion (IPR2016-01027) Download
Jun 14, 2016 8 patent_own Amneal IPR - Winchester Pro Hac Motion (IPR2016-01027) Download
May 31, 2016 6 patent_own Amneal IPR - Mandatory Notices (IPR2016-01027) Download
May 27, 2016 5 potential_ Power of Attorney Download
May 12, 2016 4 board Notice of Filing Date Accorded to Petition Download
May 11, 2016 3 petitioner Power of Attorney Download
May 11, 2016 2 petitioner Petition for Inter Partes Review of U.S. Patent No. 9,060,976 Download
May 11, 2016 1007 petitioner Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC Download
May 11, 2016 1015 petitioner International Publication No. WO 95/20947 Download
May 11, 2016 1014 petitioner U.S. Patent Publication No. 2002/0187192 Download
May 11, 2016 1025 petitioner Serial No. 10/214,412 Download
May 11, 2016 1037 petitioner U.S. Patent No. 4,861,598 (Oshlack) Download
May 11, 2016 1019 petitioner Barry Meier, U.S. Asks Painkiller Maker To Help Curb Wide Abuse Download
May 11, 2016 1028 petitioner Serial No. 13/726,324, Preliminary Amendment, Dec. 24, 2012 Download
May 11, 2016 1022 petitioner Serial No. 13/726,324 Download
May 11, 2016 1020 petitioner Brief of Plaintiffs-Appellants in Purdue Pharma L.P. et al. v. Amneal Download
May 11, 2016 1039 petitioner Oral Dosage Forms II (94) Remington The Science and Practice of Pharmacy Download
May 11, 2016 1030 petitioner Serial No. 13/726,324, Office Action, July 15, 2013 Download
May 11, 2016 1013 petitioner International Publication No. WO 97/49384 Download
May 11, 2016 1016 petitioner OxyContin, Physicians Desk Reference 2569-74 Download
May 11, 2016 1005 petitioner U.S. Patent No. 8,101,630 Download
May 11, 2016 1033 petitioner Serial No. 13/726,324, Request for Continued Examination, Jan. 5, 2015 Download
May 11, 2016 1034 petitioner Serial No. 13/726,324, Communication from Applicant, Jan. 29, 2015 Download
May 11, 2016 1008 petitioner Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC Download
May 11, 2016 1021 petitioner Reply Brief of Plaintiffs-Appellants in Purdue Pharma L.P. et al. v. Amneal Download
May 11, 2016 1036 petitioner Serial No. 13/726,324, Notice of Allowance, May 12, 2015 Download
May 11, 2016 1032 petitioner Serial No. 13/726,324, Notice of Allowance, Oct. 31, 2014 Download
May 11, 2016 1012 petitioner The Handbook of Pharmaceutical Excipients 399-400, 655 Download
May 11, 2016 1001 petitioner U.S. Patent No. 9,060,976 Download
May 11, 2016 1006 petitioner U.S. Patent Publication No. 2010/0216829 Download
May 11, 2016 1038 petitioner U.S. Provisional Patent Application No. 60/287,509 Download
May 11, 2016 1010 petitioner Curriculum Vitae of Anthony Palmieri, Ph.D. Download
May 11, 2016 1 petitioner Transmittal letter regarding exhibits Download
May 11, 2016 1002 petitioner U.S. Patent No. 8,337,888 Download
May 11, 2016 1024 petitioner Serial No. 12/653,115 Download
May 11, 2016 1009 petitioner Declaration of Dr. Anthony Palmieri Download
May 11, 2016 1011 petitioner International Publication Download
May 11, 2016 1018 petitioner Department of Justice, Information Bulletin Download
May 11, 2016 1003 petitioner Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC, Download
May 11, 2016 1004 petitioner Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC Download
May 11, 2016 1026 petitioner U.S. Provisional Patent Application No. 60/310,534 Download
May 11, 2016 1029 petitioner Serial No. 13/726,324, Supplemental Amendment, Jan. 23, 2013 Download
May 11, 2016 1035 petitioner Serial No. 13/726,324, Information Disclosure Statement, Apr. 14, 2015 Download
May 11, 2016 1023 petitioner Serial No. 13/349,449 Download
May 11, 2016 1031 petitioner Serial No. 13/726,324, Amendment and Response, Jan. 15, 2014 Download
May 11, 2016 1017 petitioner Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC 2014-1306 Download
Menu